Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors

NCT00726687 is registered in ClinicalTrials.gov with Alaunos Therapeutics as lead sponsor.

NCT NCT00726687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00726687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
Lead sponsor
Alaunos Therapeutics
Phase
Phase 1
Overall status
Terminated
Start date
June 19, 2008
Completion date
September 29, 2009
Enrollment
7 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors